Literature DB >> 15037860

Can nature's defence against malaria be mimicked by the development of host-directed therapies?

S J Foote.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15037860     DOI： 10.1038/sj.tpj.6500241

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  5 in total

1.  Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites.

Authors:  Clare M Smith; Ante Jerkovic; Hervé Puy; Ingrid Winship; Jean-Charles Deybach; Laurent Gouya; Giel van Dooren; Christopher Dean Goodman; Angelika Sturm; Hana Manceau; Geoffrey Ian McFadden; Peter David; Odile Mercereau-Puijalon; Gaétan Burgio; Brendan J McMorran; Simon J Foote
Journal:  Blood       Date:  2014-11-20       Impact factor: 22.113

Review 2.  Malaria vaccine development and how external forces shape it: an overview.

Authors:  Veronique Lorenz; Gabriele Karanis; Panagiotis Karanis
Journal:  Int J Environ Res Public Health       Date:  2014-06-30       Impact factor: 3.390

3.  Griseofulvin impairs intraerythrocytic growth of Plasmodium falciparum through ferrochelatase inhibition but lacks activity in an experimental human infection study.

Authors:  Clare M Smith; Ante Jerkovic; Thy Thuc Truong; Simon J Foote; James S McCarthy; Brendan J McMorran
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

4.  Genome-wide analysis of chemically induced mutations in mouse in phenotype-driven screens.

Authors:  Denis C Bauer; Brendan J McMorran; Simon J Foote; Gaetan Burgio
Journal:  BMC Genomics       Date:  2015-10-26       Impact factor: 3.969

5.  Treatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquine.

Authors:  Mariana Brizuela; Hong Ming Huang; Clare Smith; Gaetan Burgio; Simon J Foote; Brendan J McMorran
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.